• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

遗传性肝内胆汁淤积症的遗传改变及分子机制

Genetic alterations and molecular mechanisms underlying hereditary intrahepatic cholestasis.

作者信息

Xie Shuying, Wei Shizhang, Ma Xiao, Wang Ruilin, He Tingting, Zhang Zhao, Yang Ju, Wang Jiawei, Chang Lei, Jing Manyi, Li Haotian, Zhou Xuelin, Zhao Yanling

机构信息

School of Traditional Chinese Medicine, Southern Medical University, Guangzhou, China.

Department of Anatomy, Histology and Embryology, School of Basic Medical Sciences, Health Science Center, Peking University, Beijing, China.

出版信息

Front Pharmacol. 2023 May 31;14:1173542. doi: 10.3389/fphar.2023.1173542. eCollection 2023.

DOI:10.3389/fphar.2023.1173542
PMID:37324459
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10264785/
Abstract

Hereditary cholestatic liver disease caused by a class of autosomal gene mutations results in jaundice, which involves the abnormality of the synthesis, secretion, and other disorders of bile acids metabolism. Due to the existence of a variety of gene mutations, the clinical manifestations of children are also diverse. There is no unified standard for diagnosis and single detection method, which seriously hinders the development of clinical treatment. Therefore, the mutated genes of hereditary intrahepatic cholestasis were systematically described in this review.

摘要

一类常染色体基因突变引起的遗传性胆汁淤积性肝病会导致黄疸,这涉及胆汁酸代谢的合成、分泌异常及其他紊乱。由于存在多种基因突变,儿童的临床表现也多种多样。诊断没有统一标准,单一检测方法也严重阻碍了临床治疗的发展。因此,本综述对遗传性肝内胆汁淤积的突变基因进行了系统描述。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5803/10264785/3b9050d183ae/fphar-14-1173542-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5803/10264785/3b9050d183ae/fphar-14-1173542-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5803/10264785/3b9050d183ae/fphar-14-1173542-g001.jpg

相似文献

1
Genetic alterations and molecular mechanisms underlying hereditary intrahepatic cholestasis.遗传性肝内胆汁淤积症的遗传改变及分子机制
Front Pharmacol. 2023 May 31;14:1173542. doi: 10.3389/fphar.2023.1173542. eCollection 2023.
2
Jaundice revisited: recent advances in the diagnosis and treatment of inherited cholestatic liver diseases.黄疸再探:遗传性胆汁淤积性肝病的诊断与治疗新进展。
J Biomed Sci. 2018 Oct 26;25(1):75. doi: 10.1186/s12929-018-0475-8.
3
Advances in familial and congenital cholestatic diseases. Clinical and diagnostic implications.家族性和先天性胆汁淤积性疾病的进展。临床及诊断意义。
Dig Liver Dis. 2000 Mar;32(2):152-9. doi: 10.1016/s1590-8658(00)80403-x.
4
[Diagnosis of cholestatic disorders].[胆汁淤积性疾病的诊断]
Med Klin (Munich). 2003 Sep 15;98(9):499-509. doi: 10.1007/s00063-003-1294-5.
5
Comprehensive bile acid profiling in hereditary intrahepatic cholestasis: Genetic and clinical correlations.遗传性肝内胆汁淤积症的全面胆汁酸谱分析:遗传与临床相关性。
Liver Int. 2018 Sep;38(9):1676-1685. doi: 10.1111/liv.13714. Epub 2018 Mar 12.
6
New Insights in Genetic Cholestasis: From Molecular Mechanisms to Clinical Implications.遗传胆汁淤积症的新见解:从分子机制到临床意义。
Can J Gastroenterol Hepatol. 2018 Jul 26;2018:2313675. doi: 10.1155/2018/2313675. eCollection 2018.
7
Nonsense variant of gene in heterozygosis and benign recurrent intrahepatic cholestasis: A case report and review of literature.基因杂合性无义变异与良性复发性肝内胆汁淤积症:一例报告并文献复习
World J Hepatol. 2020 Feb 27;12(2):64-71. doi: 10.4254/wjh.v12.i2.64.
8
Progressive familial intrahepatic cholestasis.进行性家族性肝内胆汁淤积症
J Clin Exp Hepatol. 2014 Mar;4(1):25-36. doi: 10.1016/j.jceh.2013.10.005. Epub 2013 Nov 23.
9
Expanding etiology of progressive familial intrahepatic cholestasis.进行性家族性肝内胆汁淤积症病因的扩展
World J Hepatol. 2019 May 27;11(5):450-463. doi: 10.4254/wjh.v11.i5.450.
10
MYO5B Gene Mutations: A Not Negligible Cause of Intrahepatic Cholestasis of Infancy With Normal Gamma-Glutamyl Transferase Phenotype.MYO5B 基因突变:一种不可忽视的正常γ-谷氨酰转移酶表型婴儿肝内胆汁淤积症的病因。
J Pediatr Gastroenterol Nutr. 2022 May 1;74(5):e115-e121. doi: 10.1097/MPG.0000000000003399. Epub 2022 Feb 4.

引用本文的文献

1
New hope in treating progressive familial intrahepatic cholestasis in children.治疗儿童进行性家族性肝内胆汁淤积症的新希望。
World J Hepatol. 2025 Jul 27;17(7):108253. doi: 10.4254/wjh.v17.i7.108253.
2
Case report: ZFYVE19 gene mutation is associated with familial cholestasis.病例报告:ZFYVE19基因突变与家族性胆汁淤积症相关。
Front Med (Lausanne). 2025 Feb 21;11:1400475. doi: 10.3389/fmed.2024.1400475. eCollection 2024.
3
Genotypes and different clinical variants between children and adults in progressive familial intrahepatic cholestasis: a state-of-the-art review.

本文引用的文献

1
Case Report: Add-on treatment with odevixibat in a new subtype of progressive familial intrahepatic cholestasis broadens the therapeutic horizon of genetic cholestasis.病例报告:odevixibat用于进行性家族性肝内胆汁淤积症新亚型的附加治疗拓宽了遗传性胆汁淤积症的治疗视野。
Front Pediatr. 2023 Feb 14;11:1061535. doi: 10.3389/fped.2023.1061535. eCollection 2023.
2
Neonatal sclerosing cholangitis with novel mutations in (doublecortin domain-containing protein 2) in Chinese children.中国儿童中伴有(含双皮质素结构域蛋白2)新突变的新生儿硬化性胆管炎
Front Pediatr. 2023 Feb 3;11:1094895. doi: 10.3389/fped.2023.1094895. eCollection 2023.
3
进行性家族性肝内胆汁淤积症儿童与成人的基因型及不同临床变异:最新综述
Orphanet J Rare Dis. 2025 Feb 21;20(1):80. doi: 10.1186/s13023-025-03599-2.
4
Efficacy and Safety of Ileal Bile Acid Transport Inhibitors in Inherited Cholestatic Liver Disorders: A Meta-analysis of Randomized Controlled Trials.回肠胆汁酸转运抑制剂在遗传性胆汁淤积性肝病中的疗效与安全性:一项随机对照试验的荟萃分析
J Clin Exp Hepatol. 2025 May-Jun;15(3):102462. doi: 10.1016/j.jceh.2024.102462. Epub 2024 Nov 21.
5
Microvillous Inclusion Disease: An Exceedingly Rare Condition With a New Treatment.微绒毛包涵体病:一种极为罕见的疾病及新的治疗方法。
ACG Case Rep J. 2024 Oct 12;11(10):e01537. doi: 10.14309/crj.0000000000001537. eCollection 2024 Oct.
6
Association of Very Rare Variants with Clinical Features of Alagille Syndrome.非常罕见的变异与 Alagille 综合征临床特征的关联。
Genes (Basel). 2024 Aug 6;15(8):1034. doi: 10.3390/genes15081034.
7
Heritable Chronic Cholestatic Liver Diseases: A Review.遗传性慢性胆汁淤积性肝病综述
J Clin Transl Hepatol. 2024 Aug 28;12(8):726-738. doi: 10.14218/JCTH.2024.00119. Epub 2024 Jun 17.
8
Diagnosis and management of benign recurrent intrahepatic cholestasis and psychosocial stressors in an adolescent: A case report.青少年良性复发性肝内胆汁淤积症与心理社会应激源的诊断和管理:一例报告
World J Clin Cases. 2024 Jul 16;12(20):4427-4433. doi: 10.12998/wjcc.v12.i20.4427.
Biallelic Novel Splicing Variant Disrupting the Gene Function that Causes Cholestasis Phenotype and Review of the Literature.
双等位基因新型剪接变异破坏导致胆汁淤积表型的基因功能及文献综述
Mol Syndromol. 2023 Jan;13(6):471-484. doi: 10.1159/000523937. Epub 2022 Apr 28.
4
Regulation of Chromatin Accessibility by the Farnesoid X Receptor Is Essential for Circadian and Bile Acid Homeostasis In Vivo.法尼醇X受体对染色质可及性的调节对于体内昼夜节律和胆汁酸稳态至关重要。
Cancers (Basel). 2022 Dec 15;14(24):6191. doi: 10.3390/cancers14246191.
5
The Mutation Hotspots at UGT1A Locus May Be Associated with Gilbert's Syndrome Affecting the Taiwanese Population.UGT1A 基因座的突变热点可能与影响台湾人群的吉尔伯特综合征有关。
Int J Mol Sci. 2022 Oct 21;23(20):12709. doi: 10.3390/ijms232012709.
6
ATP8B1 Deficiency Results in Elevated Mitochondrial Phosphatidylethanolamine Levels and Increased Mitochondrial Oxidative Phosphorylation in Human Hepatoma Cells.ATP8B1缺乏导致人肝癌细胞中线粒体磷脂酰乙醇胺水平升高和线粒体氧化磷酸化增加。
Int J Mol Sci. 2022 Oct 15;23(20):12344. doi: 10.3390/ijms232012344.
7
Natural history of liver disease in a large international cohort of children with Alagille syndrome: Results from the GALA study.肝疾病自然史在一大国际队列的 Alagille 综合征患儿中:GALA 研究结果。
Hepatology. 2023 Feb 1;77(2):512-529. doi: 10.1002/hep.32761. Epub 2022 Oct 13.
8
Benign inheritable disorders of bilirubin metabolism manifested by conjugated hyperbilirubinemia-A narrative review.胆红素代谢良性遗传性疾病的表现为结合胆红素血症:综述。
United European Gastroenterol J. 2022 Sep;10(7):745-753. doi: 10.1002/ueg2.12279. Epub 2022 Jul 20.
9
Case Report: A Rare Heterozygous Mutation in a BRIC1 Patient: Haploinsufficiency?病例报告:一名布-加综合征患者的罕见杂合突变:单倍剂量不足?
Front Med (Lausanne). 2022 Jun 16;9:897108. doi: 10.3389/fmed.2022.897108. eCollection 2022.
10
Odevixibat treatment in progressive familial intrahepatic cholestasis: a randomised, placebo-controlled, phase 3 trial.奥贝胆酸治疗进行性家族性肝内胆汁淤积症:一项随机、安慰剂对照、3 期临床试验。
Lancet Gastroenterol Hepatol. 2022 Sep;7(9):830-842. doi: 10.1016/S2468-1253(22)00093-0. Epub 2022 Jul 1.